Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells
Background: We are developing a novel therapy for Duchenne muscular dystrophy (DMD), involving the transplantation of autologous, skeletal muscle-derived stem cells that have been genetically corrected to express dystrophin. Dystrophin is normally expressed in activated satellite cells and in differ...
Main Authors: | Jinhong Meng, John Counsell, Jennifer E. Morgan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/19/7168 |
Similar Items
-
Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01) -
Study on skeletal muscle dystrophin and neuromuscular junction in adult and young mdx mice
by: Yu-ling ZHU, et al.
Published: (2015-05-01) -
Expression of dystrophin-glycoprotein complex at the skeletal muscle sarcolemma in Duchenne muscular dystrophy
by: Lei ZHAO, et al.
Published: (2015-06-01) -
Widespread severe myodegeneration in a compound heterozygote female dog with dystrophin deficiency
by: Jessica S. Fortin, et al.
Published: (2021-05-01) -
Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice
by: Xianjun Gao, et al.
Published: (2015-01-01)